Differential involvement of protein kinase C in human promyelocytic leukemia cell differentiation enhanced by artemisinin

Seung Hyun Kim, Hyeong Joon Kim, Tae Sung Kim

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Artemisinin, a sesquiterpene lactone endoperoxide that exists in several medicinal plants, is a well-known anti-malarial agent. In this report, we investigated the effect of artemisinin on cellular differentiation in the human promyelocytic leukemia HL-60 cell culture system. Artemisinin markedly increased the degree of HL-60 leukemia cell differentiation when simultaneously combined with low doses of 1α,25-dihydoxyvitamin D3 [1,25-(OH)2D3] or all-trans retinoic acid (all-trans RA). Artemisinin by itself had very weak effects on the differentiation of HL-60 cells. Cytofluorometric analysis and cell morphologic studies indicated that artemisinin potentiated 1,25-(OH)2D3-induced cell differentiation predominantly into monocytes and all-trans RA-induced cell differentiation into granulocytes, respectively. Extracellular-regulated kinase (ERK) inhibitors markedly inhibited HL-60 cell differentiation induced by artemisinin in combination with 1,25-(OH)2D3 or all-trans RA, whereas phosphatidylinositol 3-kinase (PI3-K) inhibitors did not. Particularly, protein kinase C (PKC) inhibitors inhibited HL-60 cell differentiation induced by artemisinin in combination with 1,25-(OH) 2D3 but not with all-trans RA. Artemisinin enhanced PKC activity and protein level of PKCβI isoform in only 1,25-(OH) 2D3-treated HL-60 cells. Taken together, these results indicate that artemisinin strongly enhanced 1,25-(OH)2D3- and all-trans RA-induced cell differentiation in which PKC is differentially involved in arteminisin-mediated enhancement of leukemia cell differentiation.

Original languageEnglish
Pages (from-to)67-76
Number of pages10
JournalEuropean Journal of Pharmacology
Volume482
Issue number1-3
DOIs
Publication statusPublished - 2003 Dec 15
Externally publishedYes

Fingerprint

Protein Kinase C
Cell Differentiation
Leukemia
HL-60 Cells
Tretinoin
Phosphatidylinositol 3-Kinase
artemisinine
Sesquiterpenes
Protein C Inhibitor
Antimalarials
Lactones
Protein Kinase Inhibitors
Medicinal Plants
Granulocytes
Monocytes
Protein Isoforms
Phosphotransferases
Cell Culture Techniques

Keywords

  • Artemisinin
  • Cell differentiation
  • ERK (extracellular-regulated kinase)
  • Leukemia
  • PKC (protein kinase C)

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Differential involvement of protein kinase C in human promyelocytic leukemia cell differentiation enhanced by artemisinin. / Kim, Seung Hyun; Kim, Hyeong Joon; Kim, Tae Sung.

In: European Journal of Pharmacology, Vol. 482, No. 1-3, 15.12.2003, p. 67-76.

Research output: Contribution to journalArticle

@article{652a83e167814a66a56f5d0baefb2458,
title = "Differential involvement of protein kinase C in human promyelocytic leukemia cell differentiation enhanced by artemisinin",
abstract = "Artemisinin, a sesquiterpene lactone endoperoxide that exists in several medicinal plants, is a well-known anti-malarial agent. In this report, we investigated the effect of artemisinin on cellular differentiation in the human promyelocytic leukemia HL-60 cell culture system. Artemisinin markedly increased the degree of HL-60 leukemia cell differentiation when simultaneously combined with low doses of 1α,25-dihydoxyvitamin D3 [1,25-(OH)2D3] or all-trans retinoic acid (all-trans RA). Artemisinin by itself had very weak effects on the differentiation of HL-60 cells. Cytofluorometric analysis and cell morphologic studies indicated that artemisinin potentiated 1,25-(OH)2D3-induced cell differentiation predominantly into monocytes and all-trans RA-induced cell differentiation into granulocytes, respectively. Extracellular-regulated kinase (ERK) inhibitors markedly inhibited HL-60 cell differentiation induced by artemisinin in combination with 1,25-(OH)2D3 or all-trans RA, whereas phosphatidylinositol 3-kinase (PI3-K) inhibitors did not. Particularly, protein kinase C (PKC) inhibitors inhibited HL-60 cell differentiation induced by artemisinin in combination with 1,25-(OH) 2D3 but not with all-trans RA. Artemisinin enhanced PKC activity and protein level of PKCβI isoform in only 1,25-(OH) 2D3-treated HL-60 cells. Taken together, these results indicate that artemisinin strongly enhanced 1,25-(OH)2D3- and all-trans RA-induced cell differentiation in which PKC is differentially involved in arteminisin-mediated enhancement of leukemia cell differentiation.",
keywords = "Artemisinin, Cell differentiation, ERK (extracellular-regulated kinase), Leukemia, PKC (protein kinase C)",
author = "Kim, {Seung Hyun} and Kim, {Hyeong Joon} and Kim, {Tae Sung}",
year = "2003",
month = "12",
day = "15",
doi = "10.1016/j.ejphar.2003.09.057",
language = "English",
volume = "482",
pages = "67--76",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Differential involvement of protein kinase C in human promyelocytic leukemia cell differentiation enhanced by artemisinin

AU - Kim, Seung Hyun

AU - Kim, Hyeong Joon

AU - Kim, Tae Sung

PY - 2003/12/15

Y1 - 2003/12/15

N2 - Artemisinin, a sesquiterpene lactone endoperoxide that exists in several medicinal plants, is a well-known anti-malarial agent. In this report, we investigated the effect of artemisinin on cellular differentiation in the human promyelocytic leukemia HL-60 cell culture system. Artemisinin markedly increased the degree of HL-60 leukemia cell differentiation when simultaneously combined with low doses of 1α,25-dihydoxyvitamin D3 [1,25-(OH)2D3] or all-trans retinoic acid (all-trans RA). Artemisinin by itself had very weak effects on the differentiation of HL-60 cells. Cytofluorometric analysis and cell morphologic studies indicated that artemisinin potentiated 1,25-(OH)2D3-induced cell differentiation predominantly into monocytes and all-trans RA-induced cell differentiation into granulocytes, respectively. Extracellular-regulated kinase (ERK) inhibitors markedly inhibited HL-60 cell differentiation induced by artemisinin in combination with 1,25-(OH)2D3 or all-trans RA, whereas phosphatidylinositol 3-kinase (PI3-K) inhibitors did not. Particularly, protein kinase C (PKC) inhibitors inhibited HL-60 cell differentiation induced by artemisinin in combination with 1,25-(OH) 2D3 but not with all-trans RA. Artemisinin enhanced PKC activity and protein level of PKCβI isoform in only 1,25-(OH) 2D3-treated HL-60 cells. Taken together, these results indicate that artemisinin strongly enhanced 1,25-(OH)2D3- and all-trans RA-induced cell differentiation in which PKC is differentially involved in arteminisin-mediated enhancement of leukemia cell differentiation.

AB - Artemisinin, a sesquiterpene lactone endoperoxide that exists in several medicinal plants, is a well-known anti-malarial agent. In this report, we investigated the effect of artemisinin on cellular differentiation in the human promyelocytic leukemia HL-60 cell culture system. Artemisinin markedly increased the degree of HL-60 leukemia cell differentiation when simultaneously combined with low doses of 1α,25-dihydoxyvitamin D3 [1,25-(OH)2D3] or all-trans retinoic acid (all-trans RA). Artemisinin by itself had very weak effects on the differentiation of HL-60 cells. Cytofluorometric analysis and cell morphologic studies indicated that artemisinin potentiated 1,25-(OH)2D3-induced cell differentiation predominantly into monocytes and all-trans RA-induced cell differentiation into granulocytes, respectively. Extracellular-regulated kinase (ERK) inhibitors markedly inhibited HL-60 cell differentiation induced by artemisinin in combination with 1,25-(OH)2D3 or all-trans RA, whereas phosphatidylinositol 3-kinase (PI3-K) inhibitors did not. Particularly, protein kinase C (PKC) inhibitors inhibited HL-60 cell differentiation induced by artemisinin in combination with 1,25-(OH) 2D3 but not with all-trans RA. Artemisinin enhanced PKC activity and protein level of PKCβI isoform in only 1,25-(OH) 2D3-treated HL-60 cells. Taken together, these results indicate that artemisinin strongly enhanced 1,25-(OH)2D3- and all-trans RA-induced cell differentiation in which PKC is differentially involved in arteminisin-mediated enhancement of leukemia cell differentiation.

KW - Artemisinin

KW - Cell differentiation

KW - ERK (extracellular-regulated kinase)

KW - Leukemia

KW - PKC (protein kinase C)

UR - http://www.scopus.com/inward/record.url?scp=0345599966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345599966&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2003.09.057

DO - 10.1016/j.ejphar.2003.09.057

M3 - Article

C2 - 14660006

AN - SCOPUS:0345599966

VL - 482

SP - 67

EP - 76

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -